SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-044457 from MANGOCEUTICALS, INC. (MGRX)

MANGOCEUTICALS, INC.
Date: Dec. 11, 2023 · CIK: 0001938046 · Accession: 0001493152-23-044457

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-275993

Date
December 11, 2023
Author
/s/
Form
CORRESP
Company
MANGOCEUTICALS, INC.

Letter

Re: Mangoceuticals, Inc.

December 11, 2023

VIA EDGAR

Division of Corporation Finance

U.S. Securities & Exchange Commission

F Street, NE

Washington, DC 20549

Attn: Office of Industrial Applications and Services

Registration Statement on Form S-1

Initially filed on December 11, 2023

File No. 333-275993

Ladies and Gentlemen:

Pursuant to Rule 477(a) of the Securities Act of 1933, as amended (the “Securities Act”), Mangoceuticals, Inc, hereby requests the withdrawal of the Request for Acceleration of Effectiveness of the Registration Statement on Form S-1 (the “Request”), erroneously filed without a registration statement file number, on December 11, 2023. The Request was inadvertently filed. We wish to withdraw the Request version to correct this error. Simultaneous with the submission of this letter, we will be filing a new Request for Acceleration of Effectiveness of the Registration Statement on Form S-1 solely to rectify the EDGAR filing error specified above.

Sincerely,
/s/
Jacob Cohen

Show Raw Text
CORRESP
1
filename1.htm

December
11, 2023

VIA
EDGAR

Division
of Corporation Finance

U.S.
Securities & Exchange Commission

100
F Street, NE

Washington,
DC 20549

Attn:
Office of Industrial Applications and Services

    Re:
    Mangoceuticals,
    Inc.

    Registration
                                            Statement on Form S-1

    Initially
    filed on December 11, 2023

    File
    No. 333-275993

Ladies
and Gentlemen:

Pursuant
to Rule 477(a) of the Securities Act of 1933, as amended (the “Securities Act”), Mangoceuticals, Inc, hereby requests
the withdrawal of the Request for Acceleration of Effectiveness of the Registration Statement on Form S-1 (the “Request”),
erroneously filed without a registration statement file number, on December 11, 2023. The Request was inadvertently filed. We wish to
withdraw the Request version to correct this error. Simultaneous with the submission of this letter, we will be filing a new Request
for Acceleration of Effectiveness of the Registration Statement on Form S-1 solely to rectify the EDGAR filing error specified above.

    Sincerely,

    /s/
    Jacob Cohen

    Jacob
    Cohen

    Chief
    Executive Officer